For businesses at critical stages of growth—including start-up, diversification, and expansion—we facilitate and structure venture capital funding across a variety of sources. We work closely with portfolio companies and investors to understand and advance your goals in all aspects of financing transactions, including transaction structure and the negotiation and preparation of definitive investment agreements. Our seasoned, hands-on team provides expert counsel in the structuring and negotiating of investments and financings in emerging and growth companies. We are equally experienced and effective as investor counsel or company counsel.
Sound counsel from proven advisors. Set a firm foundation for your future.
Our Private Equity & Venture Capital attorneys fully understand the issues and concerns relating to the successful growth and evolution of your company, as well as the fund formation and investment strategies used by private equity and venture capital firms. We draw on the depth of Hinckley Allen’s various practice groups and areas of proficiency across all practice areas to formulate innovative strategies for structuring financings and acquisitions of private companies. We regularly provide advice to both private equity and venture capital firms in their fundraising and investment activities, and frequently we represent private equity and venture capital-backed companies in connection with all of their legal needs.
For clients in the private equity and venture capital arena, our team provides counsel and representation for:
- Fund formation and fundraising
- Financing alternatives
- Comprehensive company and founder representation
- Portfolio company representation
- Fund maintenance advice
- Advice on securities, tax, intellectual property, and regulatory compliance
- Structuring for financings, acquisitions, and sales of portfolio companies and other investments
We have delivered excellent results for clients in early-stage angel investment, venture capital investment rounds, equity investments, private debt and equity placements, mezzanine financing, bridge loans and secured and unsecured financings, public debt and equity offerings, bank financing, bond financing, and hybrid financing.
Improving Efficiencies in Pharmaceutical Manufacturing
We assisted our client Royal DSM, a global life sciences and material sciences company, in a $2.6 billion transaction between Patheon, Inc., and the DSM Pharmaceutical Products business group. DPx Holdings B.V., the resulting joint venture entity, is a new contract development and manufacturing organization co-owned by DSM and JLL Partners, a private equity firm.
DPx has 24 locations across the globe and employs more than 8,000 people. DPx is the corporate parent to a group of business units comprised of three distinct brands focused on growing pharmaceutical services, fine chemical products, and other proprietary technologies.
Hinckley Allen Advises Belknap-White Group in its Controlling Equity Investment in J.J. Haines Company
Hinckley Allen advised The Belknap-White Group on its controlling equity investment in J.J. Haines Company. Read more about its acquisition here.
News & Insight
Hinckley Allen is pleased to announce that James R. Burke has been named a 2019 Client Service All-Star by the BTI Consulting Group, Inc. Jim is among a select group of lawyers who earned recognition from leading general counsel and legal decision-makers f…
Jack is a seasoned corporate lawyer with over 30 years of experience. He is known for navigating clients through complex transactions, and is consistently recognized as a leader in the mergers and acquisitions field. In addition, Jack’s expertise covers …
The Committee on Foreign Investment in the United States (CFIUS), is an interagency committee under the U.S. Department of the Treasury, authorized to review certain transactions involving foreign investments in U.S. companies. They have established a new …
Hinckley Allen Partner Michael L. Koenig has been quoted by Bloomberg BNA's Health Care Reporter. Mike provides his legal opinion on what private equity firms need to consider in light of expanding False Claims Act liability and risk exposure.Private equit…